VanEck Morningstar Wide Moat Value ETF (MVAL)

Assets	$5.30M
Expense Ratio	0.49%
PE Ratio	18.27
Shares Out	150,000
Dividend (ttm)	$0.31
Dividend Yield	0.86%
Ex-Dividend Date	Dec 23, 2024
Payout Frequency	n/a
Payout Ratio	15.79%

Volume	125
Open	36.46
Previous Close	36.24
Day's Range	36.41 - 36.46
52-Week Low	27.40
52-Week High	36.47
Beta	n/a
Holdings	41
Inception Date	Mar 26, 2024

About MVAL

Fund Home Page

The VanEck Morningstar Wide Moat Value ETF (MVAL) is an exchange-traded fund that mostly invests in total market equity. The fund tracks a modified equal-weighted index of 30 to 60 value-oriented US stocks that Morningstar determines to be attractively priced and have sustainable competitive advantages. MVAL was launched on Mar 26, 2024 and is issued by VanEck.

• Asset Class: Equity
• Category: Large Value
• Region: North America
• Stock Exchange: BATS
• Ticker Symbol: MVAL
• ETF Provider: VanEck
• Index Tracked: Morningstar US Broad Value Wide Moat Focus Index

Top 10 Holdings

44.20% of assets

Name	Symbol	Weight
Thermo Fisher Scientific Inc.	TMO	5.70%
Merck & Co., Inc.	MRK	5.34%
Danaher Corporation	DHR	4.96%
United Parcel Service, Inc.	UPS	4.49%
Bristol-Myers Squibb Company	BMY	4.35%
Zimmer Biomet Holdings, Inc.	ZBH	4.12%
NIKE, Inc.	NKE	3.94%
The Campbell's Company	CPB	3.90%
Kenvue Inc.	KVUE	3.71%
Constellation Brands, Inc.	STZ	3.68%

Dividends

Ex-Dividend	Amount	Pay Date
Dec 23, 2024	$0.3133	Dec 24, 2024

Performance

MVAL had a total return of 7.44% in the past year, including dividends. Since the fund's inception, the average annual return has been 11.54%.